NASDAQ: VOGX
Vogenx Inc Stock

$14.38-2.29 (-13.74%)
Updated Nov 16, 2026
VOGX Price
$14.38
Fair Value Price
-$0.01
Market Cap
$213.62M
52 Week Low
$12.61
52 Week High
$38.41
P/E
N/A
P/B
2.61x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.01
Operating Cash Flow
N/A
Beta
1.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

VOGX Overview

Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine VOGX's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -6.47% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
VOGX
Ranked
#255 of 450

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important VOGX news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VOGX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VOGX ($14.38) is overvalued by 99,322.51% relative to our estimate of its Fair Value price of -$0.01 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
VOGX ($14.38) is not significantly undervalued (99,322.51%) relative to our estimate of its Fair Value price of -$0.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
VOGX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more VOGX due diligence checks available for Premium users.

Valuation

VOGX fair value

Fair Value of VOGX stock based on Discounted Cash Flow (DCF)

Price
$14.38
Fair Value
-$0.01
Undervalued by
99,322.51%
VOGX ($14.38) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VOGX ($14.38) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

VOGX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.61x
Industry
5.03x
VOGX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VOGX's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.9M
Profit Margin
0%

Assets to liabilities

Assets
$82.8M
Liabilities
$842.5k
Debt to equity
0.01
VOGX's short-term assets ($82.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VOGX's short-term assets ($82.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VOGX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.6M
Investing
$0.0
Financing
$84.5M

VOGX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
VOGXD$213.62M-13.74%N/A2.61x
ACIUC$212.64M-1.88%-4.28x6.46x
CYPHC$207.45M+2.94%3.26x1.49x
BCYCD$222.90M-5.64%-1.57x0.44x
IKTD$203.39M-4.61%-3.63x1.08x

Vogenx Stock FAQ

What is Vogenx's quote symbol?

(NASDAQ: VOGX) Vogenx trades on the NASDAQ under the ticker symbol VOGX. Vogenx stock quotes can also be displayed as NASDAQ: VOGX.

If you're new to stock investing, here's how to buy Vogenx stock.

What is the 52 week high and low for Vogenx (NASDAQ: VOGX)?

(NASDAQ: VOGX) Vogenx's 52-week high was $38.41, and its 52-week low was $12.61. It is currently -62.56% from its 52-week high and 14.04% from its 52-week low.

How much is Vogenx's stock price per share?

(NASDAQ: VOGX) Vogenx stock price per share is $14.38 today (as of Nov 16, 2026).

What is Vogenx's Market Cap?

(NASDAQ: VOGX) Vogenx's market cap is $213.62M, as of Nov 18, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vogenx's market cap is calculated by multiplying VOGX's current stock price of $14.38 by VOGX's total outstanding shares of 14,855,087.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.